Remote Heart Failure Management for Heart Failure

N/A

Waitlist Available

Led By Michael W Fong, MD

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 14 days after enrollment and approximately 90-days post-enrollment

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether using a digital platform to manage heart failure patients leads to better health outcomes than usual care.

Who is the study for?

This study is for English-speaking adults over 18 who've been discharged from the hospital with heart failure within the last two weeks. Participants need a working phone, internet access, and a secure place for the Bodyport device. They must be able to stand on a scale but weigh less than 375 lbs. Those with severe kidney disease, certain implants, or noncompliance history are excluded.

What is being tested?

The trial is examining how well the Bodyport Cardiac Scale works in managing heart failure remotely compared to usual care at Keck Medical Center of USC. It's checking if this virtual clinic can help patients manage their condition better at home.

What are the potential side effects?

Since this trial involves remote monitoring rather than medication or invasive procedures, traditional side effects aren't expected. However, there may be privacy concerns regarding data handling and potential stress related to technology use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 14 days after enrollment and approximately 90-days post-enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 14 days after enrollment and approximately 90-days post-enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 days after enrollment and approximately 90-days post-enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in quality of life

Scale Adherence

Secondary study objectives

Patient and provider satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: BodyPort Cardiac ScaleExperimental Treatment1 Intervention

Patient will receive the Bodyport scale with access to Bodyport care services, such as remote monitoring, educational materials, different biomarkers detected by the scale, and online access to their data

Group II: ControlActive Control1 Intervention

Patients will receive usual care and a Bodyport scale that only displays weight and weight change. No other access to care services, features, or materials will be provided during this 90 day period

Do I qualify?Apply below to find out